InvestorsHub Logo
icon url

DewDiligence

10/02/12 1:12 PM

#149823 RE: DewDiligence #149232

NVO presents favorable degludec-vs-Lantus data re nighttime glucose at EASD:

http://www.reuters.com/article/2012/10/02/us-novonordisk-idUSBRE8910BL20121002